Explora III
A newer-generation Explora Journeys ship powered by dual-fuel LNG, a little longer than EXPLORA I with more space per guest and a similar suite count.

- Cruise line
- Explora Journeys
- Operator
- MSC Group
- In service
- Since 2026
- Guest capacity
- 926 guests
- Maximum published capacity
- Ship type
- Luxury ocean cruise ship
- Anguilla visits this season
- 3
926
guests (max. published)
2026
entered service
3
Anguilla visits this season
Road Bay
anchorage

Explora Journeys
Explora III
Luxury ocean cruise ship
In Anguilla
Upcoming Anguilla visits
Next due Monday, December 14.
This ship's season at a glance
- November 5, Road Bay
- November 16, Road Bay
- December 14, Road Bay
Source: Anguilla Tourist Board cruise ship schedule. Subject to change by the cruise line. Times are Anguilla time (AST, UTC−4).
About the ship
EXPLORA III belongs to a newer generation of Explora Journeys ships.
It is designed to feel intimate and spacious at sea, combining premium accommodation, a wide choice of dining, oceanfront leisure spaces and personalised hospitality.
History
EXPLORA III entered service in 2026, part of the MSC Group's continuing investment in luxury cruising.
About Explora Journeys
Explora Journeys is the luxury ocean travel brand of the MSC Group. It entered the luxury cruise market in 2023 with a style of ocean travel inspired by the atmosphere and privacy of a superyacht.
The brand puts the emphasis on spacious accommodation, personalised hospitality, fine dining, wellness and time in each destination.
Onboard experiences
- Oceanfront suites throughout
- Several restaurants and lounges
- Pools and outdoor leisure decks
- Wellness facilities
Interesting facts
- It is about 19 metres longer than EXPLORA I.
- It has more guest space than EXPLORA I with a similar number of suites.
- It uses dual-fuel LNG technology.
- Its accommodation is almost entirely oceanfront.
Already been
Previous Anguilla visits
- Mon, Nov 16, 2026Road Bay8:00 AM → To be confirmed
- Thu, Nov 5, 2026Road Bay8:00 AM → To be confirmed



